6D-QSAR for predicting biological activity of human aldose reductase inhibitors using quasar receptor surface modeling

Table 1 Statistics for the 3D-QSAR model based on PLS analysis for AR inhibitors

LV	SSX	SSX_acc	SDEC	SDEP	R²	\({\mathrm R}^{2}_{\mathrm{acc}}\)	(LOO)	\({\mathrm{Q}}^{2}_{\mathrm{acc}}\) (LTO)	\({\mathrm{Q}}^{2}_{\mathrm{acc}}\) (5RG)
1	63.31	63.31	0.69	0.89	0.55	0.55	0.26	0.22	0.25
2	14.37	77.68	0.21	0.43	0.41	0.96	0.83	0.75	0.81
3	10.60	88.28	0.16	0.36	0.02	0.98	0.88	0.81	0.87

ISSN: 2661-801X